(GLMD) Galmed Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Galmed Pharmaceuticals | (GLMD) share price targets
Complete technical analysis of Galmed Pharmaceuticals (GLMD) by charts plus indicators, forecast predictions and share price targets for Galmed Pharmaceuticals (GLMD)
Galmed Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-07-23 View latest technical analysis
10 day averaged volume of Galmed Pharmaceuticals is 448675
Date | Daily Closing Price | Open | High | Low | Volume |
23 Wed Jul 2025 | 1.87 | 1.78 | 1.91 | 1.75 | 0.62 times |
22 Tue Jul 2025 | 1.77 | 1.88 | 1.88 | 1.61 | 0.884 times |
21 Mon Jul 2025 | 1.82 | 1.98 | 2.07 | 1.80 | 1.024 times |
18 Fri Jul 2025 | 1.83 | 2.30 | 2.30 | 1.77 | 2.544 times |
17 Thu Jul 2025 | 2.33 | 2.12 | 2.34 | 2.12 | 0.627 times |
16 Wed Jul 2025 | 2.19 | 2.06 | 2.22 | 2.05 | 0.608 times |
15 Tue Jul 2025 | 2.06 | 2.07 | 2.11 | 2.04 | 0.285 times |
14 Mon Jul 2025 | 2.09 | 1.94 | 2.13 | 1.93 | 1.025 times |
11 Fri Jul 2025 | 1.93 | 1.98 | 2.05 | 1.87 | 0.724 times |
10 Thu Jul 2025 | 2.03 | 2.16 | 2.16 | 2.03 | 0.588 times |
My analysis of stock is bearish for shortterm, and stock might move down till 1.8 or till 1.6. Use a stoploss of 1.93 and if the stock hits stoploss, then it can shoot up till 2.09
Share price targets for Galmed Pharmaceuticals (GLMD)
Target Type | Value |
Downside Target | 1.15 |
Downside Target | 1.21 |
Downside Target | 1.38 |
Downside Target | 1.42 |
Downside Target | 1.61 |
Downside Target | 1.69 |
Downside Target | 1.74 |
Upside Target | 1.90 |
Upside Target | 1.94 |
Upside Target | 2.07 |
Upside Target | 2.22 |
Upside Target | 2.34 |
Upside Target | 2.68 |
Upside Target | 3.50 |
Intraday share price targets for Galmed Pharmaceuticals (GLMD)
Target Type | Value |
Downside Intraday Target | 1.63 |
Downside Intraday Target | 1.39 |
Upside Intraday Target | 2.09 |
Upside Intraday Target | 2.31 |
Downside Intraday Target | 1.85 |
Weekly technical analysis of Galmed Pharmaceuticals (GLMD)
Date | Weekly Closing Price | Open | High | Low | Volume |
23 Wed Jul 2025 | 1.87 | 1.98 | 2.07 | 1.61 | 0.497 times |
18 Fri Jul 2025 | 1.83 | 1.94 | 2.34 | 1.77 | 0.973 times |
11 Fri Jul 2025 | 1.93 | 1.79 | 2.22 | 1.74 | 3.223 times |
03 Thu Jul 2025 | 1.83 | 1.83 | 1.90 | 1.74 | 0.394 times |
27 Fri Jun 2025 | 1.81 | 1.86 | 1.94 | 1.63 | 0.91 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Galmed Pharmaceuticals (GLMD)
Date | Monthly Closing Price | Open | High | Low | Volume |
23 Wed Jul 2025 | 1.87 | 1.83 | 2.34 | 1.61 | 0.964 times |
30 Mon Jun 2025 | 1.84 | 1.49 | 1.94 | 1.42 | 0.185 times |
30 Fri May 2025 | 1.43 | 1.34 | 1.69 | 1.15 | 0.547 times |
30 Wed Apr 2025 | 1.30 | 1.39 | 2.68 | 1.21 | 1.238 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Galmed Pharmaceuticals (GLMD)
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Galmed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Galmed Pharmaceuticals in short term but the sell signal is initial and weak.
Galmed Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Galmed Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Galmed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.94 and Galmed Pharmaceuticals (GLMD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Galmed Pharmaceuticals (GLMD) stock. Volume based technical analysis of Galmed Pharmaceuticals (GLMD) stock is negative.
Galmed Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Galmed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Galmed Pharmaceuticals in short term but the sell signal is initial and weak.
Galmed Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Galmed Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Galmed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.94 and Galmed Pharmaceuticals (GLMD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Galmed Pharmaceuticals (GLMD) stock. Volume based technical analysis of Galmed Pharmaceuticals (GLMD) stock is negative.
Galmed Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.